24 February 2022 - Deborah Wilkes
Perrigo’s agreed acquisition of HRA Pharma has won the OTCToolbox Consumer Healthcare Industry (CHi) Award for Transaction of the Year.
Responding to the news, Svend Andersen – executive vice president of Perrigo and president of Perrigo’s Consumer Self-Care International division – described HRA Pharma as the “missing link” now that Perrigo had become a “100% completely self-care player”.
Andersen said Perrigo was “really looking forward to meeting and greeting the talent at HRA Pharma and incorporating the great brands like ellaOne and Mederma into our self-care portfolio”.
Judges for this CHi Award were looking for a transaction in 2021 with the power to transform the company’s consumer healthcare presence.
Five of the nine judges for Transaction of the Year ranked Perrigo’s agreed acquisition of HRA Pharma first out of 10 candidates, and a further three judges placed it second. Judges highlighted the “very high synergies”.
Watch Perrigo's acceptance speech
The best in business development and innovation
The OTCToolbox CHi Awards honour the best in business development and innovation around the world.
Winners of the CHi Awards were decided by a panel of highly-experienced executives in the consumer healthcare field. The panel included representatives from 1HQ Creative Leap, CG Sawaya Partners, Chameleon Pharma Consulting, ECHO, Euromonitor International, EY, Healthy Brands, IQVIA Consumer Health, Jenson R+, L4i, Maestro Consulting, Manlik Pharma Consultants, Muzeable, OTCToolbox, TentaConsult Pharma & Med, as well as Ros Munday and Andy Tisman.
Transaction of the Year was one of six CHi Awards presented during the OTCToolbox 2022 Consumer Healthcare BD&I Event on 21-25 February 2022.
- Transaction of the Year
- Business Development Team of the Year
- Innovation of the Year
- Regulatory Achievement of the Year
- Self-Care Initiative of the Year
- Sustainability Project of the Year
Watch the Presentation Ceremony for the OTCToolbox 2022 CHi Awards